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Several studies have demonstrated the importance of the class I molecules of
the murine H-2 major histocompatibility complex (MHC)' as the target antigens
for allogeneic cytotoxicT lymphocytes (CTL) and also as molecules that restrict
CTL responses to viral-infected or chemically modified syngeneic target cells (1,
2) . How these class I molecules are involved in the lytic specificity of CTL
remains an unanswered question . Recent approaches to this question have used
H-2 mutant mouse strains (3), biochemical characterization and amino acid
sequencing of class I antigens (4, 5), and most recently gene transfer studies (6-
8) .
In this study we approach this question with the use of somatic cell mutants
that express altered H-2 molecules (9-11) . These cell lines, selected for the
absence of a particular serologically defined determinant on a class I molecule,
permit a precise correlation between molecular structure and function . We show
that several mutant cell lines, isolated by selection against the expression of a
serologically defined epitope which maps to the C2 domain of the H-2Dd
molecule, also exhibit changes in epitopes recognized by both allogeneic CTL
and CTL specific for hapten-modified self-determinants .
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Materials and Methods
Antibodies. The monoclonal antibodies to H-2 antigens listed in Table I have been
described elsewhere (12, 13) . They were kindly given to us by Drs . K . Ozato (National
Institute of Child Health and Human Development, Bethesda, MD) and T . Hansen
(Merck Institute, Rahway, NJ) . In addition to the D d antibodies we also had available
several Ld and K d monocloned antibodies . All of the hybridoma cell lines secreting the
monoclonal antibodies were grown in the peritoneal cavities of(BALE/c x C3H/HeJ) F,
* Supported by grants from the National Institutes of Health (NIH) (1 RO1 CA 29194-01, AI-
10702, CA-13330, 2 PO 1 AI-10702 and 1 PO I CA-1330) and from the American Cancer Society
(ACS) (1M 310 andJFRA 39) . T . A . P . was the recipient of a fellowship from the Cancer Research
Institute, Inc . and the Hearst Foundation . M. A . P . was the recipient of an AmericanJunior Faculty
Research Award . T . V . R . wa s a Scholar of the Leukemia Society of America .
' Abbreviations used in this paper: Con A, concanavalin A ; CTL, cytotoxic T lymphocyte ; FACS,
fluorescence-activated cell sorter; FBS, fetal bovine serum ; FITC, fluorescein isothiocyanate ; IL2,
interleukin 2 ; MLR, mixed lymphocyte reaction ; MHC, major histocompatibility complex ; SDS-
PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
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mice to generate ascitic fluid, and all antibodies had titers of greater than 1 :10,000 on
the ACCb cell line.
Cell Lines. The parental cell line ACCb from which the mutants were derived was
produced by transformation of (BALB/c X BALB.B10) F, neonatal bone marrow cells
with Abelson virus, as described by Rosenberg and Baltimore (14). To ensure homogeneity
of the starting population, the transformed line was cloned twice on soft agar (0 .325%
wt/vol Sea Plaque Agarose, FMC Corp., Rockland, ME) before use. These cells are grown
in suspension culture in RPMI/FBS, ie. RPMI 1640 supplemented with 10% fetal bovine
serum (FBS; Gibco Laboratories, Grand Island NY) and 5 X 10-5 M a-mercaptoethanol
and have a doubling time of ^-12 h. CTLL-A2, a cell line cytotoxic for H-2Dd targets,
was derived from peritoneal exudate cells of C57B1/6 mice immunized with the BALB/
c sarcoma Meth A and was cloned by limiting dilution in the presence of IL2 (15). This
line has been maintained in culture for nearly 3 yr in IL2-conditioned media without
antigen restimulation. The cloned CTL line, D.FL.12, which is specific for fluorescein
isothiocyanate (FITC) in association with H-21)d, was derived by Dr. Werner Haas at the
Basel Institute for Immunology (16). This line was subcloned several times (by D. B.
Wilson) and maintained in RPMI/FBS supplemented (15% vol/vol) with supernatant
from concanavalin A (Con A)-stimulated rat spleen cells.
Derivation of Mutant Cell Lines.
￿
Mutagenesis and isolation of mutant cell lines was
performed as previously described (17). ACCb cells were incubated with 600 wg/ml of
ethylmethane sulfonate (Sigma Chemical Co., St. Louis, MO) or 2 mM nitrosoethylurea
(Sigma Chemical Co.) 7 d before selection. The selection was performed by incubating 5
X 105 cells with an optimal amount (1 :100 dilution of ascites fluid) of monoclonal H-2
antibody and a 1 :3 dilution of rabbit complement in a total volume of 300 Al. After 3 h
of incubation at 37°C, the cells were cloned on soft agar (0.325% wt/vol) and after 7 d
individual clones were picked and their reactivity with several monoclonal H-2 antibodies
was tested by microcytotoxicity.
Flow MicrofluorolnetricAnalysis ofH-2 Antigen Expression.
￿
For immunofluorescence stain-
ing 106 cells in 100 ul of RPMI/FBS were incubated for 30 min on ice with an optimal
amount (10 Al) of monoclonal anti H-2D' antibody that had been conjugated with FITC
using standard procedures (18). After being stained, the cells were washed and the
fluorescence of 20,000 viable cells was measured on a FACS 11 instrument (Becton
Dickinson FACS systems, Mountain View, CA).
Labelbzg and hnnaunoprecipitation of H-2 Antigens.
￿
Labeling of cell surface molecules
with
1125 was performed by the lactoperoxidase-catalyzed reaction in the presence of
hydrogen peroxide (19). The day before, the cells were split into two aliquots, each with
3 X 107 cells in 20 ml RPMI/FBS. Tunicamycin (Sigma Chemical Co.) was added to one
of the aliquots at a concentration of 2 Wg/ml. 20 h later the cells were harvested and
washed twice in PBS, and then 2 MCi of 1 125, 25 Jul lactoperoxidase (2 mg/ml; Sigma
Chemical Co.) and 25 yl of 0.03% hydrogen peroxide were added, mixed thoroughly,
and allowed to react at room temperature for 5 min, when an additional 25 ,,1 of hydrogen
peroxide was added. After a further incubation period of 5 min the cells were washed
twice in PBS and then the membranes were solubilized in 0.5% (vol/vol) NP-40 . The
membrane extracts were then precleared by overnight incubation at 4°C in the presence
of rabbit anti-mouse immunoglobulin and sheep anti-rabbit immunoglobulin. After re-
moval of the precipitates, the supernatants were incubated with monoclonal anti-H-2
antibody and goat anti-mouse immunoglobulin, overnight at 4°C. The precipitates were
washed three times and then resuspended in either 9 M urea (for isoelectrofocusing) or
SDS buffer (for SDS-PAGE). Immediately before loading on the gels, the samples were
boiled for 2 min in the presence of 5% (vol/vol) 0-mercaptoethanol .
Biochemical Analysis of Inununoprecipitates.
￿
(a) SDS-PAGE was performed in slab gels
consisting of a 2-cm 3 .5% acrylamide stacking gel and a 10-cm 10% acrylamide resolving
gel as described by Laemmli (20). Electrophoresis was performed under a constant current
of 30 mA until the dye front was 0 .5 cm from the bottom of the gel . (b) Isoelectrofocusing
was also performed in slab gels consisting of 9 M urea, 2 .5% NP-40, and 5% ampholines
pH 5-7 (LKB, Corp.) as described by O'Farrell (21). The samples were loaded at thePOTTER ET AL.
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alkaline end of the gel (0.02 N NaOH) and ran towards the acid end (0.085% H3P0. ') for
24 h at 200 V (22).
After drying, X-ray film (Kodak XAR-5) was exposed to the gel at room temperature
without intensifying screens for a period of 10-30 d.
Generation ofAllogeneic Effector Cells.
￿
Cytotoxic cells to H-2Dd antifens were generated
in (C3H.OH X BALB.B10) F, mice using spleen cells from the H-2L loss mutant BALB/
c H-2d-2 as stimulators. For generation of secondary effector cells the mice were given an
injection of 2 X 10' BALB/c H-2d-' spleen cells s.c . 4 wk before establishing the mixed
lymphocyte reaction (MLR). Primary or secondary MLR's were performed in 24-well
dishes, with each well receiving 5 X 106 responder (C3H.OH X BALB.B10) F, spleen
cells and 5 X 106 irradiated (2,000 Rads) BALB/c H-2dm2 spleen cells in a total volume of
2 ml RPMI/FBS. After 5 d of culture at 37°C the effector cells were harvested, washed,
and tested on 51 Cr-labeled target cells.
Assays ofCell-Mediated Cytotoxicity.
￿
Cell-mediated cytotoxicity by allogeneic effector cells
and the cloned cell lines was assessed by release of 'Cr (New England Nuclear, Boston,
MA) from labeled target cells. Target cells conjugated with FITC were prepared as
described by Haas et al . (16). Target cells, either ACCb and mutants or 48-h Con A-
induced spleen cell blasts, were labeled by incubation of 106 cells in 500 ul RPMI /FBS
with 100 uCi "Cr for 60 min at 37°C. After three washes target cells were adjusted to
10'/ ml and 100 ul was added to each well of a 96-well V-bottom tray. After addition of
100 ul of effector cells at effector/target ratios indicated in the tables the cells were
pelleted and incubated for 4 h at 37°C. The percentagecytotoxicity was determined after
counting the radioactivity in 100 id of supernatant and after comparison to the maximum
and the spontaneous release, using the formula:
Specific Release =
Experimental Release - Spontaneous Release X 100.
Maximum Release - Spontaneous Release
Each value is given as the mean of triplicate determinations.
Results
Isolation ofH-2Dd Structural Mutant Cell Lines.
￿
Selections, on ACCb cells that
had been treated with a chemical mutagen, were performed with two monoclonal
antibodies to H-2Dd, 34-4-21 and 34-2-12 . Although these antibodies have
identical reactivity with inbred mouse strains (both recognizing Dd private
specificities), the two antibodies do not inhibit each other in competitive binding
studies (Potter, unpublished observation), suggesting that they react with differ-
ent Dd epitopes. From two selections using the 34-2-12 antibody as the selecting
agent, 36 individual clones were screened (Table 1): 1 1 failed to express any of
the H-2d antigens tested, i.e. they were Kd- Ld- Dd-; 6 expressed Kd but not Ld
or Dd, i .e. they were Kd+ Ld- Dd-; 9 failed to express any detectable Dd but were
still Kd+ Ld+; and 3 clones reacted with Kd and Ld antibodies, and with 34-4-21
but not with the selecting antibody 34-2-12. These latter three clones are referred
to as H-2Dd structural mutants, as they apparently have an altered Dd molecule
and are designated by their selecting antibody ACCb 34-3-12-', ACCb 34-2-
12-3 and ACCb 34-2-12'. For easier reading these three mutant cell lines will
be referred to in the text as 2.12- ', 2.12-3, and 2.12-4, respectively.
Using the 34-4-21 antibody as the selective agent we were unable to obtain
any structural mutants with a reciprocal phenotype to that described above (i .e .
34-4-21 - 34-2-12+), from ACCb in three independent selections (Table 1). The
phenotypes of 125 independent clones from selections using 34-4-21 were 79
Kd- Ld- Dd-; 21 Kd+ Ld- Dd-; 25 Kd+ Ld+ Dd-. Selections from two other H-2d1064
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TABLE I
Phenotype ofClones Arising After Anti-H-2D' Selection
* Both of these antibodies, 34-2-12 and 34-4-21, react with Dd private
specificities.
Denotes that these clones express an altered Dd molecule that reacts
with 34-4-21 but not with 34-2-12. These clones are referred to as
H-2D' structural mutants.
heterozygous cell lines have also failed to isolate any 34-4-21- 34-2-12'' clones,
although again several 34-4-21+ 34-2-12- lines were obtained .
Other mutants derived from ACCb and used in experiments described herein
include: ACCb H-2d-, a cell line that does not express any detectable H-2Kd H-
2Dd or H-2Ld; ACCb H-21)d-, which does not express any detectable 11-21)d but
is H-2Kd+ H-2Ld+ and H-2b+; ACCb H-2b-, which is a
H-2b- H-2d+ mutant and
ACCb 34-2-12-4 H-2b- (referred to as 2.12-4b- in text), which is a H-2b- mutant
isolated from the 2.124 mutant. The H-2 hemizygous mutants from ACCb and
from the 2.12-4 mutant cell line were derived by selection using the Kb antibody
Y-3, which was a kind gift of Dr. S. Nathenson.
SerologicalAnalysis ofH-2Dd Structurol Mutants.
￿
In addition to 34-2-12 and 34-
4-21 several other monoclonal antibodies react only with H-2D when tested on
strains of the H-2d haplotype. The reactivity of these antibodies with the H-2D'
structural mutants was determined by cytotoxicity testing. Two ofthe antibodies,
28-8-6 and 34-5-8, gave a weak cross-reactivity with the H-2b haplotype and
therefore these antibodies had to be tested on H-2b- (i.e. hemizygous) mutants
isolated after a second selection with H-2b antibodies on the mutants.
The results presented in Table 11 show that the mutants 2.12' and 2.12-4
react with all of the Dd antibodies except for the selecting antibody 34-2-12. The
mutant 2.12-3 does not react with several Dd antibodies-15-1-5, 23-5-21, and
34-2-12-but retains the determinant recognized by 34-4-21. The loss of only
one of the tested serological determinants of the H-2Dd molecule in the 2.12'
and 2.12-4 cell lines suggests that the effect of the mutation in these cells was
more localized than the mutation in the 2.12-3 cells.
Analysis of the reactivity of the anti-Dd monoclonal antibodies was also exam-
ined by immunofluorescence measured on the FACS. Testing with the 34-2-12
antibody confirmed that the three mutants 2.12', 2.12-3 , and 2.12-4 were in
fact 34-2-12- (Fig . 1). The reactivity of the 34-4-21 antibody conjugated with
FITC was only slightly less with 2.12-4, compared with the parental ACCb line
(Fig. 1) . Although the reactivity of 34-4-21 with 2.12' was significantly reduced,
the reaction was still greater than with a cell line ACCb H-21)d-l, which com-
pletely fails to express any Dd specificities (Fig. 1). The level of reactivity of 34-
Selecting antibody* No. of clones Phenotype
34-2-12 11 Kd- Ld- Dd-
6 Kd+ Ld- Dd-
9 Kd+ Ld+ Dd-
3 Kd+ Ld+ Ddt
34-4-21 79 Kd- Ld- Dd-
21 Kd+ Ld- Dd-
25 Kd+ Ld+ Dd-U
2
W
2
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TABLE II
Reactivity ofMonoclonal Anti-H-2D' Antibodies on ACCb and Dd Mutants
FLUORESCENCE INTENSITY
Reactivity assessed by microcytotoxicity usingthe monoclonal antibodies at an optimumconcentration
(I /200) and rabbit complement at afinaldilution of (1 /12).
+ denotes>99% of cells dead after 60 min incubation .
- denotes <5% specific kill after the same period.
VT, not tested.
BINDING OF ANTI Dd MONOCLONAL ANTIBODIESTO ACCb AND De MUTANTS
342-12
￿
34-4-21
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FIGURE 1 .
￿
Reactivity of 34-2-21 and34-2-12 antibodies with ACCb and Dd mutantsdetected
on the FAGS. The 34-4-21 antibody wasdirectly conjugated with FITC, whereas the binding
of the 34-2-12antibody wasdetected with FITC-conjugated goat anti-mouse immunoglobulin
antibody. The target cells foreach profile are as labeled.
- ACCb H 2Dd- II ACCb H-211)d-l
II
ACCb 34-2-12-1
_- ACCb 342"12-~
ACCb 34"2-12-4
ACCb 34-2-12-4 ,
. I I . I I I
34-4-21
Dd
34-2-12
Dd
Monoclonal antibodies
15-1-5 23-5-21
Dd H-2k Dd 28-8-6
Dd H-2b
34-5-8
Dd H-2
b
ACCb + + + + + +
ACCb 34-2-12' + - + + NT NT
ACCb 34-2-12-s + - - - NT NT
ACCb 34-2-12-4 + - + + NT NT
ACCb 34-2-12-4 H-2b- + - + + + +
ACCb H-2b- + + + + + +
ACCb H-2d- - - - - + +1066
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4-21 with 2.12-3 was very similar to that obtained with 2.12-1 (profile notshown) .
Although the level of reactivity of 34-4-21 with 2.12-4 was slightly less than with
ACCb, the hemizygous variant 2.12-4b- expressed an increased amount of
detectable H-2Dd compared with ACCb (profile not shown) . Overall, these
observations confirm that the mutants are 34-2-12- 34-4-21+, however, the
mutations have resulted in a variable reduction of detectable H-2Dd .
SDS-PAGE ofH-2D' Molecules .
￿
The molecular weight of Dd from 2.12-4b-
was compared with that of the unselected Dd molecule precipitated from ACCb
H-2b- . The cells were labeled with
II25, lysates were prepared, and the solubilized
membrane extract was precleared with anti-immunoglobulin . The H-2Dd mole-
cules were precipitated using the monoclonal antibody 34-5-8 and goat anti-
mouse immunoglobulin . Electrophoresis in SDS-PAGE using a 10% acrylamide
resolving gel showed that the Dd molecule precipitated from 2.12-4b- ; (Fig . 2,
lane B) ran faster than the Dd molecule precipitated from ACCb H-2b- using
either 34-5-8 (Fig . 2, lane A) or 34-2-12 (Fig . 2, lane C) . This reduction in
molecular weight was estimated to be on the order of 2,000-3,000 daltons and
was also apparent when both cell lines were grown in the presence of an inhibitor
of glycosylation, tunicamycin (data not shown), strongly suggesting that the
reduction in molecular weight was not due to an absence of one of the carbohy-
drate chains in the Dd molecule from 2.12-4b- .
IsoelectrofocusMg Comparison ofH-2D' Molecules .
￿
The H-2Dd molecules immu-
FIGURE 2 .
￿
SDS-PAGE of molecules precipitated from ACCb H-2 b- denoted P, parental-type
Dd ; and ACCb 34-2-12-" H-2d- denoted NI, mutant Dd . Membrane preparations labeled with
1125 were precipitated with Dd antibodies 34-5-8, 34-2-12 or the K' antibody 11-4-1 . Molecules
in the 40-45,000-dalton (K = 10 5) range are represented by bands approximately in the
middle of the gel .POTTER ET AL .
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noprecipitated from ACCb H-2 6- and 2.12-'b- were also compared on isoelec-
trofocusing slab gels with a pH gradient from pH 7-pH 5. The molecule
precipitated by 34-5-8 from ACCb H-2b- had at least three strong bands in the
middle of the gel (Fig . 3, lane A) . The H-2Dd molecule precipitated by 34-5-8
from 2.12-'b- also had three principal bands (Fig . 3, lane C) however, relative
to those of the precipitate from ACCb H-2b- ; these bands were shifted to the
alkaline end. The isoelectrofocusing data therefore confirms the observation
obtained by SDS-PAGE that the H-2Dd molecule expressed on 2.12-'b- is
biochemically different from the H-2Dd molecule expressed on ACCb H-2b- .
Testing ofAnti-H-2Dd Cytotoxic Lynnphocytes on the H-2Dd Mutants .
￿
The ability of
the altered H-2Dd molecules to serve as a target in anti-Ddallogeneicand hapten-
modified self cytotoxicity was tested using as effectors both cloned cytotoxicT
cell lines, and killer cells generated in primary and secondary allogeneic re-
FIGURE 3 .
￿
Isofocusing of D' molecules precipitated using Dd monoclonal antibodies 34-5-8
(lanes A-D) or 34-2-12 (lanes F_-H) . Membrane preparations were from ACCb H-2b- (lanesA
and E), ACCb 34-2-12-' H-26- (lanes C and G), ACCb H-26- cells cultured in the presence of
tunicamycin (lanes B and F) and ACCb 34-2-12-4 H-26- cells cultured in the presence of
tunicamycin (lanes D and H) .1068
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sponses.
(a) Cloned CTL Line Specificfor H-2Dd.
￿
The cytotoxicity of the anti-Dd CTL
clone, CTLL-A2, for ACCb and the Dd mutants is presented in Table III. This
line was cytotoxic for ACCb (54-56% specific lysis) but did not kill the 2.12'
(9%) or 2.12-'6- (3%) mutants. The level of cytolytic activity of CTLL-A2 on
the other mutants, 2.12' (32-45%) and 2.12-3 (39%), was reduced compared
with ACCb target cells (Table III).
The effect of monoclonal anti-H-21)d antibodies on the cytotoxicity of CTLL-
A2 for ACCb and 2.12' target cells was also investigated. The results (Fig. 4)
show that addition of either 34-2-12 or 34-4-21 significantly inhibited the
cytotoxicity of CTLL-A2 for ACCb. For 2.12' target cells only 34-4-21 andnot
34-2-12 inhibited thecytotoxicity of CTLL-A2 for these cells (Fig. 4) . The failure
of 34-2-12 to block the killing of 2.12-' by CTLL-A2 is consistent with the
serological findings that this target cell lacks the epitope recognized by 34-2-12.
The blocking of cytotoxicity by both 34-2-12 and 34-4-21 antibodies would
suggest that antisera blocking studies using antibodies to the target cell are very
prone to steric inhibition and therefore do not elucidate the fine specificity of
the epitope being recognized by cytotoxic cells.
Overall the cytotoxic reactivity of CTLL-A2 on ACCb and the H-2Dd mutants
demonstrates that CTLL-A2 recognizes an epitope different from that recog-
nized by the 34-2-12 antibody, however, this epitope has been affected by the
mutation in the 2.12-4b- cells.
(b) Cytotoxicity of Primary and Secondary Allogeneic CTL Populations.
￿
Cytotoxic
T cells specific for H-2Dd antigens were generated in a 5-d mixed lymphocyte
reaction using (C3H .OH X BALB .B10) F, responder spleen cells and irradiated
BALB/c H-2d,2 spleen cells as stimulators . Cells stimulated in this manner were
cytotoxic for ACCb with 29-38% specific release (Table IV) compared with
<3% for the H-2d- variant from ACCb (Table IV). Surprisingly, in both experi-
ments all three H-2Dd mutants were only very weakly lysed, with the possible
exception of an 18% specific kill of 2.12-3 in experiment 1 (Table IV). These
findings suggest that the vast majority of the killer cells from a (C3H.OH X
BALB.B10) F, anti-BALB/c H-2d,2 primary response are directed against epi-
topes affected by the mutations in 2.12-', 2.12-3 , and 2.12'. The finding that
TABLE III
Cytotoxicity of CTLL-A2for AM and DdMutants
The effector to target cell ratio was 10:1.
NT, not tested.
Target
Specific
Experiment 1
lysis
Experiment 2
ACCb 54 56
ACCb 34-2-12' 45 32
ACCb 34-2-12-s NT 39
ACCb 34-2-12' 9 NT
ACCb 34-21-12-4 H-26- NT 3
ACCb H-26- NT 55
ACCb H-2Dd- 6 4TARGETS
ACCB
ACCB 34-2-12-1
R KILL
￿
34-2-12
se
KILL
40
20
NO Ab
6 l2
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BLOCKING ANTIBODY
ANTIBODY DILUTION
FIGURE 4.
￿
Blocking ofthe cytotoxicreactivity ofCTLL-A2 by theaddition of50,ul doubling
dilutions of Dd antibodies 34-2-12 (left-hand panels) or 34-4-21 (right-hand panels) to the
reaction mixture. The target cells were ACCB (top panels) and ACCB 34-2-12' (bottom
panels). The level of kill in the absence of antibody is indicated in the top left corner of each
panel.
TABLE IV
Cytotoxicity ofAnti-D'Killer Cells Generated in Primary Response
E/T, Effector/Target ratio.
The effectors were generated in a 5-d mixed lymphocyte reaction in the
combination (C3H.OH x BALB.B10) F, anti-BALB/cH-2dm2. Theresults
expressed are specific lysis after a 4-h incubation with "Cr-labeled target
cells.
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the H-2Dd mutant cells were only very marginally lysed by effector cells from a
primary allogeneic response was unexpected, so we investigated the reactivity of
killer cells from a secondary response on ACCb and the H-2Dd mutants. Anti-
Dd CTL generated in a secondary response were highly cytotoxic for ACCB with
a specific release between 90-95%, compared with -2 to 3% on ACCb H-2d-
cells (Table V). When these cells were tested on the H-2Dd mutants significant
34-4-21
60
NO Ab
J 40
J
Y
20
6 l2 24 40 96
J
40
J
X NO Ab
20
6 12 24 46 96
Experiment 1: Experiment 2:
Target E/Tratio E/T ratio
10 5 30 15 6
ACCB 32 29 38 29 32
ACCB 34-2-12' 5 5 0 1 0
ACCB 34-2-12-s 18 11 6 4 4
ACCb 34-2-12-4 H-26- 5 1 8 8 5
ACCb H-2°- 53 34 29 26 16
ACCB H-2d- 1 0 2 3 31070 CYTOTOXIC T LYMPHOCYTE EPITOPES ON H-2Dd MUTANTS
TABLE V
Cytotoxicity of Anti-D° Killer Cells Generated in a Secondary Response
Cold target
BALB/c H-2dm2
C57BL/6
ACCb
ACCb 34-2-12''
ACCb 34-2-12-3
ACCb 34-2-12-' H-2''
ACCb H-26-
ACCb H-2d-
Effectors were generated in the combination (C3H.OH X BALB.B10) F,
anti-BALB/c H-2d,2 by an in vivo primary 4 wk before restimulation in a
5-d mixed lymphocyte reaction. The results expressed are specific lysis
after a 4-h incubation with "Cr-labeled target cells.
TABLE VI
Competitive Inhibition ofAnti-D° Killer Cells Generated in a Secondary
Response
Inhibitorcell: target cell ratio
100 50 25 12.5
1,5 11 11 24
56 68 32 48
22 41 26 37
52 49 55 54
33 51 37 43
42 50 36 45
11 16 16 25
49 57 49 62
Effectors were (C3H.OH X BALB.B10) F, anti-BALB/c H-2d-2 generated
in a secondary response. The targets were "Cr-labeled BALB/c H-2d-2
Con A blast cells and the effector/target ratio was 20:1 . The results are
expressedas specific lysis. In the absence ofany inhibitor cells the specific
lysis was 60%.
levels of lysis were observed 2.12-' (21-31%), 2.12-3 (49-52%) and 2.12-'b-
(18-31%, Table V). The observation that the level of kill of the mutants was
lower than that seen for ACCb cells was further investigated by cold target
competition. As presented in Table V1, addition of excess unlabeled BALB/c H-
2d"'2 cells completely inhibited cytotoxicity of the CTL population for labeled
BALB /c H-2
d,n2 cells. The effect was specific, as addition of C57BL/6 or ACCb
H-2d- cells did not affect the level of kill. Although not as complete as the
inhibition obtained with BALB/c H-2d,2 cells, addition of unlabeled ACCb cells
significantly reduced the killing of BALB /c H-2d",2 cells. The effect of the
addition of unlabeled mutant H-2Dd cells was less marked; addition of 2.12-3
produced the greatest reduction of cytotoxicity by the three mutants, whereas
the addition of 2.12-' or 2.12-4b- cells gave only a slight reduction in the level
of cytotoxicity . For none of these three mutants was the reduction in cytotoxicity
as great as that obtained with ACCb, suggesting that none of the mutants
possessed all of the epitopes recognized by the heterogeneous population of
Target
100
Effector/Target ratio
50 10
ACCb 95 91 90
ACCb 34-2-12' 31 29 21
ACCb 34-2-12-3 50 52 49
ACCb 34-2-12-" H-2''- 24 31 18
ACCb H-26' 69 67 65
ACCb H-2d- -6 -2 3secondary cytotoxic cells.
(c) H-2Dd Mutant Cells as Targetsfor a CTL Clone Specificfor FITC.
￿
ACCb and
the Dd mutant cell lines were labeled with FITC and tested for their ability to be
lysed by a cloned line of CTL, D.FL.12, which has lytic specificity for FITC-
labeled target cells expressing the H-2Dd molecule . The results (Fig. 5) showed
that the H-2Dd mutants 2.12' and 2.12-4b- were not killed by DYL.12, 2.12-s
was lysed to some extent, but not to the extent of the parental line ACCb or its
hemizygous variant ACCb H-26-. The results indicate that the H-2Dd determi-
nant(s) involved in restriction of anti-FITC T cell-mediated lysis has also been
altered by the mutations that led to the serologically detected changes.
Recent studies have provided major insights into the structure and genetic
organization of H-2 class 1 molecules. An important tool for an understanding
POTTER ET AL.
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Discussion
EFFECTOR :TARGET RATIO
FIGURE 5.
￿
Cytotoxicity of D.FL.12 for AM and D°mutant cell lines. The target cellswere
conjugated with FITC as ciescribed by Haas et al. (16) before testing. (0) FITC-conjugated
cells. (O) Nonconjugated cells.
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of H-2 structure-function relationships has been the mutant strains of mice
isolated by Melvold, Kohn, Egorov, and Bailey (23-25). Comparisons ofmutant
and wild type phenotypes have been made in many functional systems, including
histogeneic studies ofallogeneic determinants recognized by Tcells in vivo or in
vitro (26), investigation of the T cell repertoire to allogeneic determinants (27),
andcharacterization ofdeterminants restricting viral (28, 29) or minor histocom-
patibility antigen (30) responses. In addition to the H-2 mutants isolated in vivo,
mutants in H-2 class 1 molecules can also be isolated from somatic cells in culture
(9, 10). The latter procedure makes it possible to isolate cells that have lost the
ability to express a particular H-2 determinant.
We have isolated three cell lines expressing mutant Dd molecules and have
characterized the mutant molecule serologically, biochemically, and in assays
investigating the functional role ofDd both as a target for CTL and as a molecule
restricting responses to hapten-modified self-determinants. The effect of the
mutation in the three cell lines is summarized in Table VII. In addition,
biochemical analysis demonstrated that the mutant Dd molecule from the
2.12-4b- mutant cell line is -2,000-3,000 daltons smaller than normal Dd and
as this difference was also seen in cells treated with tunicamycin, the reduction
in size is apparently not due to the absence of a carbohydrate chain. Analysis by
isoelectrofocusing confirmed that the H-2Dd molecule expressed on this cell line
is structurally altered.
Relationship between Serologically Defined Determinants and Determinants Recognized
by Allogeneic CTL. The major finding from these studies is that the mutant cell
lines selected for by serological alterations also show changes in epitopes recog-
nized by T cells (Table VII). The failure of CTLL-A2 to react with 2.12-4
demonstrated that the mutation that produced the nonexpression of the 34-2-
12 serological specificity by this cell line also altered the epitope recognized by
CTTL-A2. However, the cytotoxicity of CTLL-A2 for the two other 34-2-12-
mutants, suggested that the CTL clone recognizes a determinant different from
the serological determinant. It was striking that the two mutants, 2.12' and
2.12-4, which have a similar serological profile demonstrated such a contrast in
their susceptibility to cytotoxicity by CTLL-A2. It should be pointed out that
TABLE V11
Suinniary ofSerological and Functional Testing ofDd Mutants
The level of lysis, represented by -, +, ++, +++ is designated using the level seen for ACCb as
ACCb ACCb 34-2-12'
Cell line
ACCb 34-2-12-3 ACCb 34-2-12-4
Nonreactive Dd antibodies Nil 34-2-12 34-2-12 34-2-12
15-1-5
23-5-21
Sensitivity to killer cells
CTLL-A2 +++ ++ ++ -
1 ° MLR +++ - + -
2° MLR +++ + ++ +
D.FL.12 (anti-FITC) +++ - + -POTTER ET AL.
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the failureof CTLL-A2 to kill 2.12' was not because these targets were resistant
to T cell killing, because anti-Kb or anti-L' killer cells readily killed these cells
(data not shown). In addition, the analysis by immunofluorescence of the expres-
sion of H-2Dd on these cells together with the observation that 2.12' and 2.12-3
cells were killed by CTLL-A2, demonstrated that the inability of CTLL-A2 to
kill these targets was not caused by a quantitative reduction in the amount of H-
2Dd expressed on the mutant cells.
In our efforts to further correlate serologically defined and CTL-defined
determinants, we investigated the inhibition of the cytotoxicity of CTLL-A2 for
ACCb by the addition of monoclonal antibodies. It was found that the binding
of any monoclonal to the target molecule inhibited the CTL. This was the case
even for antibodies such as 34-2-12 and 34-4-21, which bind to separate deter-
minants on the Dd molecule and in competitive binding experiments do not
inhibit the binding of each other (Potter, unpublished observations). This implies
that antibody blocking studies of the epitopes recognized by T cells are affected
by steric constraints, and it is therefore difficult from antisera blocking studies
to make conclusions about the fine specificity of the target epitope.
Using recombined Dd-Ld genes, recent studies have mapped the Dd serological
specificities to particular domains (31). For the antibodies used in this study, 34-
4-21, 34-5-8, and 23-5-21 react with specificities in the N or C1 domains, whereas
the determinant recognized by 34-2-12 is in the C2 domain. In apparent conflict
with our findings, that in mutants selected by using an antibody 34-2-12 which
recognizes a determinant in the C2 domain there are also changes to the
determinants recognized by allogeneic CTL, is a recent observation that using
recombined Dd-Ld genes, all of the determinants recognized by allogeneic CTLs
map exclusively to the N and C1 domains (32). The failure to detect any
allogeneic CTL determinants in the C2 domain using the recombined genes was
consistent with amino acid DNA sequencing data, which demonstrated that the
greatest homology between MHC class I molecules of different loci and from
different haplotypes, was located in the C2 domain. At present we cannot resolve
the differences between our data and that obtained using the recombined genes,
but if there are no determinants recognized by allogeneic CTL in the C2 domain
then presumably the mutation in the mutants that we have isolated must have
affected T cell-recognized determinants in N or C1 while having no effect on
the serologically defined epitopes in these domains. An alternative explanation
could be that there are some epitopes formed by interactions between the C2
and C1 domains; such determinations might not be generated using recombinant
genes in which the C1 and C2 domains come from different sources. It is
interesting to note that the mouse strain B10 H-2d,1, which has altered Dd and
Ld molecules, shows a similar Dd phenotype to 2.12' in that it reacts with all
monoclonal Dd antibodies except 34-2-12 (Dr. T. Hansen, personal communi-
cation) and it is not killed by the anti-Dd CTL line CTLL-A2 (Palladino and
Potter, unpublished observations).
Comparison ofEpitopes Recognized by Allogeneic CTL and Epitopes Involved in Anti-
Modified-selfResponses. The finding that a CTL specific for FITC, D.FL.12, did
not react with 2.12-' and 2.12-'b-, and reacted only weakly with 2.12-3 dem-
onstrated that the mutations had affected the Dd epitope(s) that restricts the anti-1074
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FITC cytotoxic response. As the patterns of reactivity of the CTLL-A2 and
D.FL.12 CTL cell lines were different from each other, these two cell lines must
recognize different Dd epitopes. These findings therefore suggest that it is
possible to express a H-2 class I molecule that has epitopes recognized by
allogeneic CTLbut does not function as a restricting element to certain antigens.
Comparison ofH-2 Somatic Cell Mutants and H-2 Mutant Mice.
￿
Although the Dd
mutants were selected for by alterations in serologically defined determinants,
there were also alterations in the determinants recognized by T cells. However,
in the H-2Kb mutant mouse strains, which were selected for by changes in T cell-
defined determinants (skin graft rejection), there are relatively few established
alterations in the expression of H-2K' determinants defined by monoclonal
antibodies or alloantisera (33). Studies on the allogeneic determinants expressed
on H-2Kb have demonstrated that there are many different or overlapping,
epitopes recognized by T cells, whereas our data showed that mutants isolated
by their inability to express a serologically defined determinant had accompa-
nying alterations in epitopes recognized by T cells. One possible interpretation
of these findings is that in comparison to Kb there are fewer epitopes on Dd that
are recognized by T cells. An alternate explanation is that the mutations that we
have observed in the H-2D' mutants have altered the conformation of the H-
2Dd molecules in a manner such that they are not recognized by T cells with
anti-H-2D' specificity, while the reactivity with the monoclonal antibodies has
remained unaffected. The H-2Dd mutant molecule that we characterized bio-
chemically had a substantial reduction in size compared with Dd molecules from
unselected cells. Although it is likely that this reduction did significantly affect
the conformation of the molecule, all of the monoclonal anti-Dd antibodies, with
the exception of the selecting antibody, still reacted with the altered molecule.
Summary
We have generated several cell lines that express an altered H-2Dd molecule.
These cell lines, which were selected for by the failure to express the serological
specificity reacting with the monoclonal antibody 34-2-12, have also undergone
alterations in epitopes recognized by CTL. One of the mutants, 2.12-4 was not
killed by an allogeneic anti-D' CTL line, CTLL-A2, even though this line was
cytotoxic for the parental cell line and two other 34-2-12- mutant lines. Two of
the 34-2-12- mutant lines had an identical serological profile using other mon-
oclonal Dd antibodies, however these two mutants differed markedly in their
susceptibility to cytotoxicity by CTLL-A2. In addition to the determinants
recognized by allogeneic CTL we also examined the effect of the mutation on
the determinants involved in restricting the anti-FITC modified-self-cytotoxic
response. An anti-FITC-D' CTL line did not react with two of the mutants and
reacted only weakly with the other mutant, demonstrating not only that the Dd
epitopes recognized by this cell line and the allogeneic CTL were different, but
also that it is possible for a H-2 class I molecule to express epitopes recognized
by allogeneic CTL but not epitopes that function as restricting elements to
certain antigens. The observation that both T cell- and B cell-defined deter-
minants were altered in these mutant cell lines is in contrast to the findings, with
the mutant mouse strains which were selected for by changes in T cell-definedPOTTER ET AL.
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determinants, which show few, if any, alterations to serological specificities.
Characterization of T cell-recognized epitopes expressed on serologically se-
lected somatic cell variants may therefore prove to be most useful for the study
of structure-function relationships of H-2 class I molecules.
We are indebted to Drs. Ted Hansen and Keiko Ozato for generously providing the
monoclonal antibodies used in this study, to Drs. Pierre Golstein and Ted Hansen for
critically reviewing this manuscript, and to Ms. Kathy Meringolo for expert technical
assistance with the FRCS analyses. We wish to thank Ms. Rosina Passela for the preparation
of this manuscript.
Receivedfor publication 5 May 1983 and in revisedform 27June 1983.
References
1 . Zinkernagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic T cells:
studies on the biological role of polymorphic major transplantation antigens deter-
mining T-cell restriction-specificity, function and responsiveness. Adv. Immunol.
27:52.
2 . Shearer, G. M., and A. M . Schmitt Verhulst. 1977 . Major histocompatibility complex
restricted cell mediated immunity. Adv. Immunol. 25:55.
3 . Klein, J. 1978. H-2 mutations: their genetics and effect on immune functions. Adv.
Immunol. 26 :55 .
4 . Nairn, R., K . Yamaga, and S. G. Nathenson. 1980 . Biochemistry of the gene products
from murine MHC mutants. Annu. Rev. Genetics. 14:241 .
5 . Coligan, J. E., T. J. Kindt, H. Uehera, J. Martinko, and S. G. Nathenson. 1981 .
Primary structure of a murine transplantation antigen . Nature (Load.). 291 :35 .
6. Goddenow, R. S., M. McMillan, A. Orn, M. Nicolson, N . Davidson, J. A. Frelinger,
and L. Hood. 1982. Identification of a BALB/c H-2L° gene by DNA-mediated gene
transfer. Science (Wash. DC). 215:677 .
7 . Evans, G. A ., D. H. Margulies, R. D. Camerini-Otero, K. Ozato, and J . G. Seidman.
1982. Structure and expression of a mouse major histocompatibility antigen gene H-
2Ld. Proc. ~Vatl. Acad. Sci. USA 79:1994.
8 . Margulies, D. H., G. A. Evans, K. Ozato, R. D. Camerini-Otero, K. Tanaka, E.
Apella, and J. G. Seidman. 1983 . Expression of H-2D' and H-2Ld mouse major
histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J.
Immunol. 130:463.
9. Rajan, T. V ., and E. D. Halay. 1981 . Anti H-2 hybridoma antibodies as immunose-
lective agents. I. Isolation of forward and reverse mutations for reactivity with a
monoclonal antibody. hnmunogenetics. 14:253.
10. Holtkamp, B., M. Cramer, H. Lemke, and K. Rajewsky. 1981 . Isolation of a clonal
cell line expressing variant H-2K` using fluorescence activated cell sorting. Nature
(Land .) . 289:66.
11 . Chapdelaine, J. M., T. V. Rajan, S. G. Nathenson, F. Lilly. 1981 . Use of hybridoma-
resistant variant cell lines to study H-2D6 /FMR specific cytotoxic T cells. Imnzunoge-
netics. 14 :429.
12. Ozato, K., T. H. Hansen, and D. H . Sachs. 1980. Monoclonal antibodies to mouse
MHC antigens. II. Antibodies to the H-2L' antigen, the products of a third poly-
morphic locus of the major histocompatibility complex. J. Immunol. 125:2263.
13. Ozato, K., N. M. Mayer, and D. H. Sachs. 1982. Monoclonal antibodies to mouse
MHC antigens. IV. A series of hybridoma clones producing anti H-2d antibodies and
an examination of expression of H-2d antigens of these cells. Transplantation (Bolti-1076
￿
CYTOTOXIC T LYMPHOCYTE EPITOPES ON H-2D° MUTANTS
more). 34:113.
14 . Rosenberg, N ., and D. Baltimore. 1976. A quantitative assay for transformation of
bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 143 :1453 .
15 . Palladino, M . A., Y. Obata, E. Stockert, and H. F. Oettgen. 1983. Characterization
of IL-2 dependent cytotoxic T cell clones. I. Specificity cell surface phenotype and
susceptibility to blocking by Lyt antisera. Cancer lies. 43 :572 .
16 . Haas, W., J. Mathur-Rochat, H. Pohlit, M . Nabholz, and H. von Boehmer. 1980.
Cytotoxic T cell responses to haptenated cells. III. Isolation and specificity analysis
of continuously growing clones. Eur. J. Imnaunol. 10:828.
17 . Rajan, T. V. 1977 . H-2 antigen variants in a cultured heterozygous mouse leukemia
cell line. 1muiunogenetics. 4:105.
18. Goding, J. W. 1980 . Antibody production by hybridomas. J. Immunol. Methods.
39:285 .
19. Michaelson, J ., L . Flaherty, E. Vitetta, and M. D. Poulik. 1977 . Molecular similarities
between the Qa-2 alloantigen and other gene products of the 17th chromosome of
the mouse. J. Exp. Med. 145:1066.
20. Laemmli, U . K. 1970. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature (Load.). 227 :680.
21 . O'Farrell, P. H. 1975. High resolution two-dimensional electrophoresis of proteins.
J. Biol. Cheap. 250:4007 .
22. Michaelson, J., L. Flaherty, Y. Bushkin, and H. Yudkowitz. 1981 . Further biochemical
data on Qa-2. lanaamnogenetics. 14:129 .
23. Bailey, D. W., and H . I. Kohn. 1965 . Inherited histocompatibility changes in progeny
of irradiated and unirradiated inbred mice. Transplant. Bull. 7 :424.
24. Egorov, I. K., and Z. K. Blandova. 1968. The genetic homogeneity of the inbred
mice bred at Stolbouya farm . 11. Skin grafting test. Genetika. 12:63.
25. Melvold, R. W., and H. I. Kohn. 1976. Eight new histocompatibility mutations
associated with the H-2 complex. Immunogenetics. 3:185 .
26. Melief, C . J. M ., L. P. DeWaal, M . Y. Van Der Meulen, R. W. Melvold, and H. 1.
Kohn. 1980 . Fine specificity ofalloimmune cytotoxic T lymphocytes directed against
H-2K. A study with k`' mutants. J. Exp. Med. 151 :993.
27. Sherman, L. A. 1982 . Influence of the major histocompatibility complex on the
repertoire of allospecific cytolytic T lymphocytes. J. Exp. Med. 155:380.
28. Blanden, R. V., M. B. C. Dunlop, H. 1. Kohn, and 1. F. C. McKenzie. 1976. Effects
of four H-2K mutations on virus-induced antigens recognized by cytotoxic T cells.
Iowninogeuetics. 3 :541 .
29 . Hurwitz, J . L., S. Pan, P. J . Wettstein, and P . C. Doherty. 1983. Cross reactivity
patterns of vaccinia-specific cytotoxic T lymphocytes from H-2k' mutants. Immuno-
genetics. 17 :79 .
30 . Wettstein, P . J. 1982. H-2 effects on cell-cell interactions in the response to single
non H-2 alloantigens . V. Effects of H-2K6 mutations on presentation of H-4 and H-
3 alloantigens.J. Imnaunol. 128:2629 .
31 . Evans, G. A., D. H. Margulies, B. Shykind, J . G. Seidman, and K. Ozato. 1982. Exon
shuffling: mapping polymorphic determinants on hybrid mouse transplantation an-
tigens . Nature (Load.). 300:755.
32. Ozato, K., G. A. Evans, B. Shykind, D. H . Margulies, and J. G. Seidman. 1983 .
Hybrid H-2 gene products assign domains recognized by alloreactive T cells. Proc.
A'ad. Acad. Sci. USA. 80:2040 .
33. Hammerling, G. J., E. Rusch, N. Tada, S. Kimura, and U . Hammerling. 1982 .
Localization of allodeterminants on H-2K6 antigens determined with monoclonal
antibodies and H-2 mutant mice. Proc. Nod. Acad. Sci. USA . 79:4737 .